Moderna is exploring the purchase of BioNTech's manufacturing facilities in Germany that are slated for closure, viewing existing plants as a more attractive option than building new ones, while seeking a long-term partnership with the German government and better regulatory conditions; Senate Democrats are advancing a drug pricing agenda focused on expanding Medicare drug price negotiation, incorporating international reference pricing, ending exemptions for blockbuster drugs, and extending cost relief to employer-sponsored and individual market coverage, alongside measures to reduce generic drug markups and supply chain inflation.
Sources:
Senate Democrats Outline Drug Pricing Agenda to Cut Patient Costs
Baden-Württemberg US-Impfstoffhersteller Moderna interessiert an BioNTech-Werken: Was das bedeutet
New vaccination centre opens in MyZeil
Biontech: Moderna hat Interesse an Werken in Deutschland
Where to get a booster vaccine in Berlin - The Berliner
US-Konzern Moderna prüft Kauf von Biontech-Werken
A Berlin shopping mall's vaccine success story – DW – 10/30/2021
Moderna (MRNA) Eyes Manufacturing Facilities in Germany Amid Bio
Where can one get a Covid booster vaccination at short notice?
Moderna interested in Germany production, sees opportunity in ...
Moderna dealers – Laminat, Venyl, Treppen, Wand und Decke
Democrats rev up high-stakes final push to lower drug prices